Peers of Vitaspring Biomedical Co. Ltd (VSBC)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
478.86x
As of Aug 11, 2023
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Aug 11, 2023 | 478.86x |
| Aug 10, 2023 | 351.49x |
| Jun 5, 2023 | 510.79x |
| May 8, 2023 | 478.86x |
| May 5, 2023 | 478.86x |
| May 4, 2023 | 478.86x |
| May 2, 2023 | 478.86x |
| Mar 28, 2023 | 474.08x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison